Angotti J. Vincent's most recent trade in Talphera Inc. was a trade of 365,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2025 | 365,000 | 365,000 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 0.59 per share. | 02 Apr 2025 | 213,310 | 403,769 (0%) | 0% | 0.6 | 125,000 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2025 | 61,000 | 474,769 (0%) | 0% | 0 | Common Stock | |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 14 Feb 2025 | 10,575 | 190,459 (0%) | 0% | 0.7 | 7,085 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 10 Feb 2025 | 3,517 | 201,034 (0%) | 0% | 0.6 | 2,181 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.63 per share. | 10 Feb 2025 | 3,515 | 204,551 (0%) | 0% | 0.6 | 2,214 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 05 Dec 2024 | 5,000 | 208,066 (0%) | 0% | 0.6 | 3,200 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 27 Nov 2024 | 5,000 | 203,066 (0%) | 0% | 0.7 | 3,650 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 30 Aug 2024 | 7,260 | 198,066 (0%) | 0% | 1.0 | 7,598 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 12 Jun 2024 | 4,570 | 179,502 (0%) | 0% | 1.0 | 4,438 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 12 Jun 2024 | 4,126 | 174,932 (0%) | 0% | 1.0 | 4,013 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 12 Jun 2024 | 1,304 | 180,806 (0%) | 0% | 1.1 | 1,404 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 11 Mar 2024 | 8,000 | 170,806 (0%) | 0% | 1.1 | 8,995 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 11 Mar 2024 | 1,000 | 162,806 (0%) | 0% | 1.1 | 1,115 | Common Stock |
| Talphera Inc. | Vincent J. Angotti | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 03 Mar 2024 | 1,623 | 161,806 (0%) | 0% | 1.3 | 2,110 | Common Stock |
| Talphera Inc. | Angotti J. Vincent | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 352,000 | 352,000 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc. | J. Angotti Vincent | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 58,667 | 153,429 (0%) | 0% | 0 | Common Stock | |
| Talphera Inc. | Vincent Angotti J. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. | 10 Feb 2024 | 3,723 | 94,762 (0%) | 0% | 1.1 | 4,095 | Common Stock |
| Talphera Inc. | Angotti J. Vincent | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. | 10 Feb 2024 | 3,320 | 98,485 (0%) | 0% | 1.1 | 3,652 | Common Stock |
| Acelrx Pharmaceuticals Inc | Angotti J. Vincent | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 13 Dec 2023 | 10,000 | 101,805 (0%) | 0% | 0.7 | 7,268 | Common Stock |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.31 per share. | 03 Mar 2023 | 1,703 | 63,836 (0%) | 0% | 1.3 | 2,231 | Common Stock |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 117,000 | 117,000 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 19,500 | 68,860 (0%) | 0% | 0 | Common Stock | |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. | 10 Feb 2023 | 3,321 | 65,539 (0%) | 0% | 1.7 | 5,579 | Common Stock |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. | 06 Feb 2023 | 1,982 | 49,360 (0%) | 0% | 2.0 | 4,004 | Common Stock |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.22 per share. | 07 Jun 2022 | 46,400 | 1,016,919 (1%) | 0% | 0.2 | 10,333 | Common Stock |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. | 03 Mar 2022 | 23,051 | 970,519 (1%) | 0% | 0.4 | 9,377 | Common Stock |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 780,000 | 780,000 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 390,000 | 1,006,628 (1%) | 0% | 0 | Common Stock | |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. | 11 Feb 2022 | 23,058 | 983,570 (1%) | 0% | 0.4 | 9,255 | Common Stock |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 06 Feb 2022 | 27,318 | 616,628 (0%) | 0% | 0.4 | 11,780 | Common Stock |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 1,000,000 | 1,000,000 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 200,000 | 636,980 (0%) | 0% | 0 | Common Stock | |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.63 per share. | 11 Feb 2021 | 23,052 | 427,887 (0%) | 0% | 2.6 | 60,627 | Common Stock |
| Acelrx Pharmaceuticals Inc | Vincent J. Angotti | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. | 06 Feb 2021 | 25,059 | 450,939 (0%) | 0% | 2.6 | 64,903 | Common Stock |